Industry News 22 Oct 2026

Armando Rubio, Vicapsys CEO, on Pharmaceutical Supply Chain Resilience, U.S. Manufacturing and Expanding Acces...

Source: Haute Living •By april irene donelson •1 min read

As pharmaceutical supply chains become an increasingly important economic and national security priority, Vicapsys Life Sciences, Inc. is pursuing a strategy that combines pharmaceutical distribution, domestic manufacturing, and access to underserved healthcare markets. In an exclusive conversation with Haute Living, Armando Rubio, Chief Executive Officer and Chairman of Vicapsys Life Sciences, discusses his company’s approach The post Armando Rubio, Vicapsys CEO, on Pharmaceutical Supply Chain Resilience, U.S. Manufacturing and Expanding Acces... appeared first on Haute Living.

This is a short summary. The full story is published by Haute Living.

Read full story at Haute Living
#haute partners#pharmaceutical#supply chain and logistics

Related news

Industry News
Torrent Pharma Profit Falls 9.6 Per Cent, Dr Reddy’s Slumps 36 Pc In Q2 FY27

Torrent Pharmaceuticals’ Q2 FY27 net profit fell 9.6% to Rs 534 crore, although revenue rose 50.8% to Rs 4,979 crore as expenses climbed 70.9%. Dr…

The Free Press Journal• 23 Oct 2026 •1 min read
#financial markets#fpj shorts#pharma
Read story
Industry News
Palleon Pharmaceuticals Presents Phase 2 Results for HLX79/E-602 in Primary Membranous Nephropathy at ASN Kidney Week…

Palleon Pharmaceuticals, a clinical-stage biotechnology company developing glycan editing therapeutics for autoimmune disease and cancer, today…

Financialcontent• 23 Oct 2026 •1 min read
#pharmaceutical#pharmaceuticals#phase 2
Read story
Industry News
Lupin appoints Brian Savage as President, Chief Legal Officer

He joins Lupin from Teva Pharmaceuticals, where he held several senior leadership roles since 2015, serving most recently as executive vice…

The Hindu - Business Line• 23 Oct 2026 •1 min read
#companies#pharmaceutical#pharmaceuticals
Read story
Industry News
FDA flags more Olympus safety problems in import block and warning letter

The FDA import alert broadens the scope of a 2025 import action covering dozens of endoscopes and comes two weeks after a new warning letter…

Medtech Dive• 22 Oct 2026 •1 min read
#supply chain and logistics#warning letter
Read story
Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Trending tags
#pharma #pharmaceutical #fda approval #diseases #pharmaceuticals #clinical trial #fda approves #pharma and healthcare #biosimilar #phase iii #science and innovations #research #vaccine #drug #world news
Browse by category
Industry News 89 Regulatory 5
Top sources
A Abnewswire 10 stories
I Indianpharmapost 5 stories
F Finanznachrichten.de 5 stories
K Kalkine Media 4 stories
F FDA 4 stories
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit